<DOC>
	<DOCNO>NCT01318642</DOCNO>
	<brief_summary>This study phase 2 , multicenter , randomize , double-blind , active placebo-controlled trial AMG 479 placebo combination gemcitabine first-line therapy locally advance unresectable adenocarinoma pancreas . Approximately 150 subject randomize 1:1 ratio AMG 479 gemcitabine , gemcitabine placebo . Randomization stratify ECOG ( 0 1 ) . Gemcitabine give day 1 , 8 , 15 , follow AMG 479 day 1 15 every 28 day cycle . Treatment continue radiographic disease progression , unacceptable toxicity , withdrawal consent , start new anti-cancer therapy .</brief_summary>
	<brief_title>Ganitumab Locally Advanced Unresectable Adenocarcinoma Pancreas</brief_title>
	<detailed_description>This study phase 2 , multicenter , randomize , double-blind , active placebo-controlled trial AMG 479 placebo combination gemcitabine first-line therapy locally advance unresectable adenocarinoma pancreas . Approximately 150 subject randomize 1:1 ratio AMG 479 gemcitabine , gemcitabine placebo . Randomization stratify ECOG ( 0 1 ) . Gemcitabine give day 1 , 8 , 15 , follow AMG 479 day 1 15 every 28 day cycle . Treatment continue radiographic disease progression , unacceptable toxicity , withdrawal consent , start new anti-cancer therapy .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Subjects must histologically cytologically confirm locally advanced adenocarcinoma pancreas unresectable , per institutional practice Radiologically measurable and/or nonmeasurable disease define RECIST version 1.1 Eastern Cooperative Oncology Group ( ECOG ) score 0 1 Men woman &gt; /= 18 year age Adequate organ function Early ( stage I ) metastatic ( stage IV ) disease Islet cell , acinar cell carcinoma , nonadenocarcinoma , ( eg , lymphoma , sarcoma , etc ) , adenocarcinoma originate biliary tree cystadenocarcinoma External biliary drain Currently treat previously treat biologic , small molecule , immunotherapy , chemotherapy ( ie , include gemcitabine ) , agent pancreatic cancer Currently treat previously treat radiotherapy , chemoradiotherapy pancreatic cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Adenocarcinoma</keyword>
	<keyword>pancreas</keyword>
	<keyword>pancreatic cancer</keyword>
	<keyword>local</keyword>
	<keyword>unresectable</keyword>
	<keyword>stage II</keyword>
	<keyword>stage III</keyword>
</DOC>